Guidance document - Nonprescription topical nasal decongestants labelling standard

Guidance document - Nonprescription topical nasal decongestants labelling standard This labelling standard describes the requirements necessary to receive market authorisation ( Drug identification number (DIN)) for nonprescription topical nasal decongestant products containing oxymetazoline hydrochloride or xylometazoline hydrochloride as a single ingredient for use in adults and children 12 years of age and older to relieve nasal congestion. 2021-09-09 Health Canada open-ouvert@tbs-sct.gc.ca Health and SafetyNon-prescription topical nasal decongestantslabelling standardmarket authorisationoxymetazoline hydrochloridexylometazoline hydrochloride Guidance document - Nonprescription topical nasal decongestants labelling standardHTML https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/applications-submissions/guidance-documents/nonprescription-drugs-labelling-standards/nonprescription-topical-nasal-decongestants-labelling-standard.html Guidance document - Nonprescription topical nasal decongestants labelling standardHTML https://www.canada.ca/fr/sante-canada/services/medicaments-produits-sante/medicaments/demandes-presentations/lignes-directrices/medicaments-vente-libre-normes-etiquetages-produits-pharmaceutiques/norme-etiquetage-medicaments-decongestionnants-nasaux-topiques-vendus-sans-ordonnance.html

This labelling standard describes the requirements necessary to receive market authorisation ( Drug identification number (DIN)) for nonprescription topical nasal decongestant products containing oxymetazoline hydrochloride or xylometazoline hydrochloride as a single ingredient for use in adults and children 12 years of age and older to relieve nasal congestion.

Data and Resources

Similar records